Fig. 12
From: Molecular docking and dynamics reveal novel CDK6 inhibitors for targeted glioblastoma therapy

Graphical representation of dynamic cross-correlation matrix (DCCM) analysis of the lead compound 21 and CCL.
From: Molecular docking and dynamics reveal novel CDK6 inhibitors for targeted glioblastoma therapy

Graphical representation of dynamic cross-correlation matrix (DCCM) analysis of the lead compound 21 and CCL.